BNP Paribas Financial Markets’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-47,508
| Closed | -$1.28M | – | 4125 |
|
|
2022
Q4 | $1.28M | Sell |
47,508
-9,797
| -17% | -$258K | ﹤0.01% | 2021 |
|
|
2022
Q3 | $1.03M | Buy |
57,305
+30,353
| +113% | +$485K | ﹤0.01% | 2465 |
|
|
2022
Q2 | $335K | Sell |
26,952
-45,557
| -63% | -$503K | ﹤0.01% | 2867 |
|
|
2022
Q1 | $966K | Sell |
72,509
-13,870
| -16% | -$186K | ﹤0.01% | 2345 |
|
|
2021
Q4 | $1.34M | Buy |
86,379
+78,879
| +1,052% | +$1.51M | ﹤0.01% | 2380 |
|
|
2021
Q3 | $168K | Sell |
7,500
-178
| -2% | -$3.91K | ﹤0.01% | 3105 |
|
|
2021
Q2 | $175K | Buy |
7,678
+3,907
| +104% | +$82.2K | ﹤0.01% | 2900 |
|
|
2021
Q1 | $77.6K | Buy |
3,771
+3,686
| +4,336% | +$83.9K | ﹤0.01% | 3462 |
|
|
2020
Q4 | $2.35K | Hold |
85
| – | – | ﹤0.01% | 3996 |
|
|
2020
Q3 | $1.19K | Buy |
+85
| New | +$1.58K | ﹤0.01% | 4080 |
|
|
2020
Q2 | – | Sell |
-88
| Closed | -$664 | – | 4413 |
|
|
2020
Q1 | $664 | Sell |
88
-79
| -47% | -$886 | ﹤0.01% | 4138 |
|
|
2019
Q4 | $2.59K | Buy |
167
+13
| +8% | +$131 | ﹤0.01% | 4208 |
|
|
2019
Q3 | $801 | Hold |
154
| – | – | ﹤0.01% | 4409 |
|
|
2019
Q2 | $1.39K | Buy |
154
+93
| +152% | +$1.39K | ﹤0.01% | 4353 |
|
|
2019
Q1 | $1.46K | Hold |
61
| – | – | ﹤0.01% | 4132 |
|
|
2018
Q4 | $1K | Sell |
61
-39
| -39% | -$769 | ﹤0.01% | 3921 |
|
|
2018
Q3 | $2.65K | Hold |
100
| – | – | ﹤0.01% | 4220 |
|
|
2018
Q2 | $2.29K | Hold |
100
| – | – | ﹤0.01% | 4235 |
|
|
2018
Q1 | $2.13K | Buy |
100
+85
| +567% | +$1.29K | ﹤0.01% | 4093 |
|
|
2017
Q4 | $190 | Hold |
15
| – | – | ﹤0.01% | 4130 |
|
|
2017
Q3 | $232 | Hold |
15
| – | – | ﹤0.01% | 4140 |
|
|
2017
Q2 | $176 | Sell |
15
-31
| -67% | -$384 | ﹤0.01% | 4162 |
|
|
2017
Q1 | $540 | Buy |
+46
| New | +$527 | ﹤0.01% | 3835 |
|
Other funds holding MYOV
BNP Paribas Financial Markets's MYOV Position: Q1 2023 in Review
BNP Paribas Financial Markets sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 47,508 shares — an estimated $1.28M sold.
BNP Paribas Financial Markets first reported a position in MYOV in Q1 2017 and held it in 23 quarters. The position peaked at $1.34M in Q4 2021. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.
- BNP Paribas Financial Markets reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
- BNP Paribas Financial Markets sold 47,508 Myovant Sciences Ltd. shares in Q1 2023, an estimated $1.28M.
- BNP Paribas Financial Markets first reported a position in Myovant Sciences Ltd. in Q1 2017 and held it in 23 quarters.
- BNP Paribas Financial Markets's Myovant Sciences Ltd. position peaked at $1.34M in Q4 2021.
- 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2023, filed 12 May 2023.